Drug Approval | June 15, 2022
Eli Lilly gets FDA approval for alopecia drug
Alopecia areata usually presents as a few small bald patches in the head
Alopecia areata usually presents as a few small bald patches in the head
The Ayushman Bharat Digital Mission (ABDM) aims to replicate this success in healthcare delivery by building an equitable, accessible and inclusive ecosystem
Increased and timely testing will enable early identification of COVID cases and help to curb spread of the infection among the community
The IDCF programme is being implemented from 13th June to 27th June, 2022 in the states/UTs and the goal is to attain zero child deaths due to childhood diarrhoea
India’s first oncology laboratory for comprehensive Cancer Diagnostic services
Amarex Clinical Research guides its client to phase II of FDA trials
The production and supply in Canada are designed to address the growing need for no-carrier-added Lutetium-177 (n.c.a. Lu-177) in North America
Cantourage introduces second Clever Leaves medical cannabis product to the German market
Tislelizumab is now approved in nine indications in China
Sam Samad will be departing Illumina on July 8, 2022, after serving as CFO for more than five years.
Subscribe To Our Newsletter & Stay Updated
